The Council’s scientists’ unparalleled contributions have made the country succeed not only in essential crops’ production but in the various fields of agricultural and allied sciences as well at the global level”: Shri Tomar – Posted On: 09 JUN 2022 8:56 PM by PIB Delhi
Union Minister of Agriculture & Farmers’ Welfare. Shri Narendra Singh Tomar launched Animal Vaccine and other Diagnostic Kits developed by the ICAR-National Research Centre on Equines, Hisar, Haryana during a function.
The Ancovax Vaccine on Equines is an inactivated SARS-CoV-2 Delta (COVID-19) Vaccine for Animals. The immunity induced by Ancovax neutralizes both Delta and Omicron Variants of SARS-CoV-2. The Vaccine contains inactivated SARS-CoV-2 (Delta) antigen with Alhydrogel as an adjuvant. It is safe for dogs, lions, leopards, mice, and rabbits.
Appreciating the Equine Research Center, Shri Tomar said that this institute has developed six vaccines and 19 diagnostic technologies for the prevention of infectious diseases in equines and other animals, out of which four have been launched.
The diagnostic kits launched today include CAN-CoV-2 ELISA Kit. It is a sensitive and specific nucleocapsid protein-based indirect ELISA Kit for antibody detection against SARS-CoV-2 in Canines. There are no laboratory animals required for the preparation of the antigens. The Kit is made in India and a patent has been filed for the same. No other comparable kits for the detection of antibodies in Canines are available on the market.
The Equine DNA Parentage Testing Kit is a powerful genomic technology for parentage analysis. The Parentage among the Horses can be definitely established using Multiplex PCR Technology to compare allele sizes. At ICAR-NRC on Equines, an optimized 21 DNA Market Panel is being used for Parentage testing.
In the PMC article, given a vaccine has adverse side effects for humans, what will happen to the animals? Are they, too, facing the side effects now? Did animals require a vaccine against COVID?
SARS-CoV-2 and adverse reactions to SARS-CoV-2 vaccinations show a tropism for neuronal structures and tissues. This narrative review was conducted to collect and discuss published data about neurological side effects of SARS-CoV-2 vaccines in order to discover the type, frequency, treatment, and outcome of these side effects. The most frequent neurological side effects of SARS-CoV-2 vaccines are headache, Guillain-Barre syndrome (GBS), venous sinus thrombosis (VST), and transverse myelitis. Other neurological side effects occur in a much lower frequency. Neurological side effects occur with any of the approved vaccines, but VST particularly occurs after vaccination with vector-based vaccines. Treatment of these side effects is not at variance from similar conditions due to other causes. The worst outcome of these side effects is associated with VST, why it should not be missed and treated appropriately in due time. In conclusion, safety concerns against SARS-CoV-2 vaccines are backed by an increasing number of studies reporting neurological side effects. The most frequent of them are headaches, GBS, VST, and transverse myelitis. Healthcare professionals, particularly neurologists involved in the management of patients having undergone SARS-CoV-2 vaccinations, should be aware of these side effects and should stay vigilant to recognize them early and treat them adequately.